LAST PRICE - AT THE CLOSE
DRUG is UP 14% since the begininning of the year
DRUG is UP 6% ABOVE 20 day SMA
DRUG is UP 36% ABOVE 200 day SMA
PROFITABLE: NO
EPS: $-0.711744
EARNINGS MOMENTUM: YES
0.18% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
![]() |
THE STOCK IS 28.0% AWAY FROM ALL-TIME HIGHS OF $123.75 |
![]() |
DRUG IS UP 14% SINCE THE BEGINNING OF THE YEAR |
![]() |
DRUG IS UP 188% OVER THE PAST 12 MONTHS |
![]() |
DRUG IS UP 30% OVER THE PAST 1 MONTH |
![]() |
8% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
![]() |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
![]() |
DRUG moved up 0 in the previous minute |
![]() |
DRUG is up 2 over the last hour |
![]() |
DRUG is up 0.1% over the last 5 days |
![]() |
DRUG is 2.3 above its 8 day SMA |
| $86.36 | ![]() DAY |
$91.00 |
| $85.50 | ![]() PREVIOUS DAY |
$90.50 |
| $85.50 | ![]() WEEK |
$92.00 |
| $68.53 | ![]() MONTH |
$92.39 |
| $23.18 | ![]() YEAR |
$123.75 |
DRUG is mentioned N/A less than normal on
DRUG is mentioned N/A times in an average day on